Corcept Therapeutics (CORT) PT Raised to $42 at Truist Securities
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $117.17 +2.36%
Rating Summary:
7 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
7 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Truist Securities analyst Joon Lee raised the price target on Corcept Therapeutics (NASDAQ: CORT) to $42.00 (from $36.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Ashok Leyland Ltd. (AL:IN) PT Raised to INR194 at Nomura/Instinet
- argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
